RECOVAC Repeated Vaccination Study

Clinical trial NCT05030974 · COMPLETED

Trial details

NCT number: NCT05030974
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Kidney Diseases Vaccine Response Impaired SARS-CoV2 Infection

Start date: 2021-10-21
Primary completion: 2022-03-12
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.